These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 16740622

  • 1. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ, Sempowski GD, McKenna SE, Laskowitz DT, Colton CA, Vitek MP.
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
    Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, Landreth GE, Pershadsingh HA, Weinberg G, Heneka MT.
    Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
    [Abstract] [Full Text] [Related]

  • 3. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J.
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [Abstract] [Full Text] [Related]

  • 4. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
    Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A.
    J Neuroimmunol; 2004 Mar; 148(1-2):146-53. PubMed ID: 14975595
    [Abstract] [Full Text] [Related]

  • 5. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A.
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
    [Abstract] [Full Text] [Related]

  • 6. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis.
    Moore CS, Earl N, Frenette R, Styhler A, Mancini JA, Nicholson DW, Hebb AL, Owens T, Robertson GS.
    J Pharmacol Exp Ther; 2006 Oct; 319(1):63-72. PubMed ID: 16809479
    [Abstract] [Full Text] [Related]

  • 7. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
    Jung S, Donhauser T, Toyka KV, Hartung HP.
    J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
    [Abstract] [Full Text] [Related]

  • 8. Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis.
    Pifarre P, Prado J, Baltrons MA, Giralt M, Gabarro P, Feinstein DL, Hidalgo J, Garcia A.
    Acta Neuropathol; 2011 Apr; 121(4):499-508. PubMed ID: 21234581
    [Abstract] [Full Text] [Related]

  • 9. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF.
    Neuroimmunomodulation; 2008 Apr; 15(1):76-83. PubMed ID: 18667803
    [Abstract] [Full Text] [Related]

  • 10. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse.
    Iruretagoyena MI, Tobar JA, González PA, Sepúlveda SE, Figueroa CA, Burgos RA, Hancke JL, Kalergis AM.
    J Pharmacol Exp Ther; 2005 Jan; 312(1):366-72. PubMed ID: 15331658
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice.
    Nomura T, Abe Y, Kamada H, Shibata H, Kayamuro H, Inoue M, Kawara T, Arita S, Furuya T, Yamashita T, Nagano K, Yoshikawa T, Yoshioka Y, Mukai Y, Nakagawa S, Taniai M, Ohta T, Serada S, Naka T, Tsunoda S, Tsutsumi Y.
    J Control Release; 2011 Jan 05; 149(1):8-14. PubMed ID: 20036293
    [Abstract] [Full Text] [Related]

  • 12. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, Bigini P, Barbera S, Fumagalli E, Mennini T, Vezzani A, Rizzi M, Coleman T, Cerami A, Brines M, Ghezzi P, Bianchi R.
    J Neuroimmunol; 2006 Mar 05; 172(1-2):27-37. PubMed ID: 16337691
    [Abstract] [Full Text] [Related]

  • 13. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F.
    Autoimmunity; 2008 Aug 05; 41(5):405-13. PubMed ID: 18568646
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic approach by Aloe vera in experimental model of multiple sclerosis.
    Mirshafiey A, Aghily B, Namaki S, Razavi A, Ghazavi A, Ekhtiari P, Mosayebi G.
    Immunopharmacol Immunotoxicol; 2010 Sep 05; 32(3):410-5. PubMed ID: 20233107
    [Abstract] [Full Text] [Related]

  • 15. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H.
    PLoS Med; 2007 Apr 05; 4(4):e124. PubMed ID: 17425404
    [Abstract] [Full Text] [Related]

  • 16. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF, Zhu YN, Ni J, Zhong XG, Tang W, Re YD, Shi LP, Wan J, Yang YF, Yuan C, Nan FJ, Lawson BR, Zuo JP.
    J Pharmacol Exp Ther; 2006 Nov 05; 319(2):799-808. PubMed ID: 16914558
    [Abstract] [Full Text] [Related]

  • 17. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L.
    Brain; 2011 Sep 05; 134(Pt 9):2722-35. PubMed ID: 21908876
    [Abstract] [Full Text] [Related]

  • 18. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
    Papadopoulos D, Rundle J, Patel R, Marshall I, Stretton J, Eaton R, Richardson JC, Gonzalez MI, Philpott KL, Reynolds R.
    J Neurosci Res; 2010 Feb 01; 88(2):346-59. PubMed ID: 19658199
    [Abstract] [Full Text] [Related]

  • 19. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y.
    J Neuroimmunol; 2008 Feb 01; 194(1-2):107-14. PubMed ID: 18207251
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR, Kanwar RK, Krissansen GW.
    Brain; 2004 Jun 01; 127(Pt 6):1313-31. PubMed ID: 15130951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.